DESFLURAN VA SEVOFLURANNING KARDIOPROTEKTIV TA'SIRLARI MEXANIZMALARI

##article.authors##

  • Tashkenbaeva Eleonora Negmatovna
  • Nasyrova Zarina Akbarovna
  • Saidov Maksud Arifovich
  • Yusupova Moxinabonu Farruxovna
  • Boltaqulova Sarvinoz Dilshodovna

##article.subject##:

desfluran, sevofluran, reperfuziya, postkonditsionerlash, postkonditsionerlash, reperfuziya shikastlanishi, sun’iy qon aylanish

##article.abstract##

Konditsionirlangan miokard aslida ishemik reperfuziya shikastlanishini boshqarishda muhim strategiyadir. Postkonditsionirlangan anesteziya tushunchasi juda qiziq, uning ta'siri asosiy daqiqada (reperfuziya, ishemik reperfuziya shikastlanishlari boshlanganda), ushbu kardioprotektiv mexanizmlarning faollashuvi ishemik reperfuziya shikastlanishiga olib keladigan mexanizmlarni yengib chiqqanda sodir bo'ladi. Desfluran va sevofluran - bu yurak operatsiyasi paytida tez-tez ishlatiladigan uchuvchan anestetikdir. Ushbu sharh potentsial kardioprotektiv strategiya sifatida erta reperfuziya paytida qo'llaniladigan desfluran va sevofluran samaradorligiga qaratilgan. Ushbu agentlarning kardioprotektiv ta'siriga asoslangan mexanizmlar va ularning konditsionirlikni keltirib chiqarish qobiliyati batafsil muhokama qilindi, bu reaktiv kislorod turlarini yaratish va mitoxondriyalarga ta'sirini ta'kidladi. Bu, albatta, ushbu strategiyaning haqiqiy ta'sirini tasdiqlash uchun zarur bo'lgan randomizatsiyalangan klinik sinovlarni boshlash uchun asosni tiklash uchun yetarli bo'lishi mumkin.

Библиографические ссылки

A Araszkiewicz, M Grygier, M Pyda, J Rajewska, M Lesiak, S Grajek

Postconditioning attenuates early ventricular arrhythmias in patients with high-risk ST-segment elevation myocardial infarction. J Cardiol, 65 (2015), pp. 459-465

A Khan, A Binabdulhak, Y Alastal, et al. Cardioprotective role of ischemic post-conditioning in acute myocardial infarction : a systematic review and meta-analysis

Am Hear J, 168 (2014), pp. 512-521

A Zangrillo, V Testa, V Aldrovandi, et al. Volatile agents for cardiac protection in noncardiac surgery: a randomized controlled study. J Cardiothorac Vasc Anesth, 25 (2015), pp. 902-907

C Kikuchi, S Dosenovic, M Bienengraeber Anaesthetics as cardioprotectants - translatability and mechanism Br J Pharmacol, 172 (2015), pp. 2051-2061

D Obal, S Dettwiler, C Favoccia, H Scharbatke, B Preckel, W Schlack

The influence of mitochondrial KATP-channels in the cardio-protection of preconditioning and post-conditioning by sevoflurane in the rat in vivo Anesth Analg, 101 (2005), pp. 1252-1260

J Zhang, C Wang, S Yu, et al. Sevoflurane post-conditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3 K/AKT/mTOR signalling

Sci Rep, 4 (2014), p. 7317

JL Guerrero Orriach, MG Ortega, MR Aliaga, P Iglesias, MR Navarro, J Mañas

Prolonged sevoflurane administration in the off-pump coronary artery bypass graft surgery: beneficial effects. J Crit Care, 879 (2013), pp. e13-e18

J Hellström, A Öwall, CR Martling, P Sackey. Inhaled Isoflurane Sedation During Therapeutic Hypothermia After Cardiac Arrest: A Case Series Crit Care Med, 42 (2014), pp. 161-166

G Landoni, F Guarracino, C Cariello, et al. Volatile compared with total intravenous anaesthesia in patients undergoing high-risk cardiac surgery: a randomized multicentre study. Br J Anaesth, 113 (2014), pp. 955-963

KA Kortekaas, A van der Baan, LP Aarts, et al. Cardiospecific sevoflurane treatment quenches inflammation but does not attenuate myocardial cell damage markers: a proof-of-concept study in patients undergoing mitral valve repair. Br J Anaesth, 112 (2014), pp. 1005-1014

MV Cohen, JM Downey Combined cardioprotectant and antithrombotic actions of platelet P2Y12 receptor antagonists in acute coronary syndrome: just what the doctor ordered. J Cardiovasc Pharmacol Ther, 19 (2014), pp. 179-190

M Zaugg, E Lucchinetti Letter by Zaugg and Lucchinetti regarding article, “Randomized comparison of sevoflurane versus propofol to reduce perioperative myocardial ischemia in patients undergoing noncardiac surgery”. Circulation, 127 (2013), pp. e875-e876

N Jivraj, F Liew, M Marber Ischaemic post-conditioning: cardiac protection after the event

Anaesthesia, 70 (2015), pp. 598-612

SG De Hert, PJ Van der Linden, S Cromheecke, et al. Cardioprotective Properties of Sevoflurane in Patients Undergoing Coronary Surgery with Cardiopulmonary Bypass Are Related to the Modalities of Its Administration Anesthesiology, 101 (2004), pp. 299-310

S Lemoine, L Zhu, G Beauchef, et al. Signaling pathways involved in desflurane-induced post-conditioning in human atrial myocardium in vitro. Anesthesiology, 109 (2008), pp. 1036-1044

ZQ Zhao, JS Corvera, ME Halkos, et al.

Inhibition of myocardial injury by ischemic post-conditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol, 285 (2003), pp. H579-H588

YL Zhang, YT Yao, NX Fang, CH Zhou, JS Gong, LH Li Restoration of autophagic flux in myocardial tissues is required for cardio-protection of sevoflurane post-conditioning in rats. Acta Pharmacol Sin, 35 (2014), pp. 758-769

V Barsukevich, M Basalay, J Sanchez, et al. Distinct cardio-protective mechanisms of immediate, early and delayed ischaemic post-conditioning Basic Res Cardiol, 110 (2015), p. 452

YT Yao, DH Liu, LH Li Comparison of cardio-protective effects induced by different modalities of sevoflurane conditioning in isolated rat hearts. Perfusion (2015)

Advance Access published on June 9, pii: 0267659115590833

Загрузки

##submissions.published##

2021-07-23